MedPath

Psychological Intervention modifiEs Outcome of Patients With implAntable Cardioverter dEfibrillator: The PEACE Study

Not Applicable
Completed
Conditions
Implantable Defibrillator User
Interventions
Other: Individual interview with a qualified psychologist
Registration Number
NCT02902458
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

This study aims to investigate whether follow-up with a psychologist has an impact on the outcome of patients with an implantable automated defibrillator.

Detailed Description

The implantation of an ICD in primary prevention is known to increase the rates of anxiety and depression, which can reach up to 45% and 35% respectively in this patient population. Several studies have reported that psychological accompaniment for these patients can alleviate the symptoms of anxiety and/or depression. Therefore, we aim to investigate the utility of psychological follow-up for a period of 1 year after first implantation of an ICD for primary prevention.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • adult patients (aged 18 years or over)
  • indication for implantation of an ICD for primary prophylaxis
  • written informed consent provided
  • patients with social security coverage
Exclusion Criteria
  • patients under legal tutorship or guardianship
  • patients with no social security coverage
  • patients still within the exclusion period after participation in another clinical trial, as indicated by the national registry of clinical trial volunteers
  • patients unable to complete the questionnaires (language barriers, mentally deficient, illiteracy or dementia)
  • patients awaiting heart transplant
  • patients who refuse to provide written informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Psychological follow-upIndividual interview with a qualified psychologistPatients undergoing implantation of an ICD for primary prevention will have an individual interview with a qualified psychologist in addition to standard medical follow-up.
Primary Outcome Measures
NameTimeMethod
Mini International Neuropsychiatric Interview score12 months after implantation
Secondary Outcome Measures
NameTimeMethod
Quality of life12 months after implantation

Measure of patient's quality of life using the Short Form (SF) 36 item questionnaire

State-Trait Anxiety Inventory12 months after implantation

Measure of state and trait anxiety

Minnesota Living with Heart Failure questionnaire12 months after implantation

Evaluation of the quality of life in patients with heart failure

Trial Locations

Locations (1)

CHU Besancon

🇫🇷

Besancon, France

© Copyright 2025. All Rights Reserved by MedPath